MENU

News

Latest News Articles

News

07.14.20

FDA Grants Clearance for Neurovascular Artificial Intelligence System
  • KEYWORDS:
  • FDA Clearance
  • Ischemic stroke
  • Stroke

News

07.10.20

Strokes Associated with COVID-19 May Be More Severe With Higher Mortality
  • KEYWORDS:
  • Coronavirus
  • COVID-19
  • Ischemic stroke
  • Stroke

News

07.10.20

FDA Approves Expanded OnabotulinumtoxinA Label for Pediatric Spasticity
  • KEYWORDS:
  • Child neurology
  • FDA Approvals
  • Neuromuscular disease
  • Spasticity

News

07.09.20

Blood Biomarker May Predict Concussion Severity and Duration
  • KEYWORDS:
  • Brain Concussion
  • Headache
  • TBI
  • traumatic brain injury
TBI

News

07.08.20

Aducanumab for Alzheimer Disease Treatment Submitted to FDA for Approval
  • KEYWORDS:
  • Aducanumab
  • Alzheimer Disease
  • Early onset Alzheimer disease
  • FDA Approvals

News

07.07.20

FDA Clears Automated ASPECTS Scoring from CT 
  • KEYWORDS:
  • Ischemic stroke
  • Neuroimaging
  • Stroke

News

07.06.20

The Women Neurologist Group and the Alliance for Advancement of Neuroscience Advocate for Continued use of Telemedicine 
  • KEYWORDS:
  • Alzheimer Disease
  • Epilepsy
  • Multiple sclerosis
  • Practice management
  • Sleep
  • Stroke

News

06.30.20

Chronic Stress of Discrimination Increases Hypertension Risk in African Americans
  • KEYWORDS:
  • high blood pressure
  • hypertension
  • Intracranial hypertension
  • Stroke

News

06.30.20

FDA Grants Orphan Drug Designation for Primary Mitochondrial Myopathies Treatment
  • KEYWORDS:
  • Neuromuscular disease
  • peroxisome proliferator activated receptor
  • primary mitochondrial myopathies
  • REN001

News

06.26.20

FDA Approves Fenfluramine for Treatment of Seizures Associated with Dravet Syndrome
  • KEYWORDS:
  • Dravet syndrome
  • FDA Approvals
  • Fenfluramine
  • Seizures

News

06.24.20

Higher Rates of Alzheimer Disease Not Related to Longer Life in Women
  • KEYWORDS:
  • Alzheimer Disease
  • Early onset Alzheimer disease

News

06.24.20

Phase 2 Clinical Trial for Stem-Cell Treatment of Alzheimer Disease Planned
  • KEYWORDS:
  • Alzheimer Disease
  • Autologous Treg cells
  • Early onset Alzheimer disease
  • MSC-NTF
  • NurOwn

News

06.23.20

FDA Grants Premarket Approval for Neurostimulation System for Chronic Back Pain
  • KEYWORDS:
  • 2020 Drug and Device Approvals
  • implantable neurostimulation system
  • Pain

News

06.22.20

Enrollment Begins for Phase 1b Clinical Trial of T-cell Immunotherapy for Progressive Multiple Sclerosis 
  • KEYWORDS:
  • allogeneic EBV T-cell immunotherapy
  • ATA188
  • Multiple sclerosis

News

06.19.20

Metabolomics May Be a Potential Biomarker for Autism
  • KEYWORDS:
  • Autism
  • Child neurology
Show More
This Month's Issue
Teleneurology

Stephen M. Gollomp, MD, and Paul G. Mathew, MD, DNBPAS, FAAN, FAHS

Teleneurology Billing and Coding

Brad Klein, MD, MBA, FAAN, FAHS, FAANEM, and Raissa Villanueva MD, MPH, FAAN